Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer

Written by BRIDGES Team

PMID: 30946090 DOI: 10.1097/SLA.0000000000003284

Selected by Mr Joel Lambert

BRIDGES Team
Previous

The Diagnostic Accuracy of the Faecal Immunohistochemical Test in Identifying Significant Bowel Disease in a Symptomatic Population
Next

Two-year results of the randomized clinical trial DILALA comparing laparoscopic lavage with resection as treatment forperforated diverticulitis